# Efficacy and Safety of Dengue Vaccine in Healthy Children

> **NCT00842530** · PHASE2 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 4002 (actual)

## Conditions studied

- Dengue Virus
- Dengue Fever
- Dengue Hemorrhagic Fever
- Dengue Diseases

## Interventions

- **BIOLOGICAL:** CYD Dengue Vaccine
- **BIOLOGICAL:** Inactivated rabies virus vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00842530
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-09
- **Final completion:** 2014-02
- **Target enrollment:** 4002 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842530, "Efficacy and Safety of Dengue Vaccine in Healthy Children". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00842530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*